US to pay Sanofi, GlaxoSmithKline up to $2.1B for development, 100M doses of coronavirus vaccine

(By Katie Adams for Becker’s Hospital Review)

The U.S. government signed a contract July 31 with Sanofi and GlaxoSmithKline to pay up to $2.1 billion for the development and supply of a COVID-19 vaccine.  Continue reading article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org